107 related articles for article (PubMed ID: 1352068)
1. The antithrombin III gene polymorphism in Japan: examination for haplotypes relevant to disordered antithrombin III biosynthesis.
Oguma Y; Sakuragawa N; Hiraga K
Thromb Res; 1992 Mar; 65(4-5):519-31. PubMed ID: 1352068
[TBL] [Abstract][Full Text] [Related]
2. [Restriction fragment length polymorphisms of the antithrombin III gene--examination of the normal Japanese, abnormal AT III (Toyama) and AT III deficient families].
Oguma Y; Sakuragawa N; Hiraga K
Rinsho Byori; 1989 Apr; Spec No 81():64-74. PubMed ID: 2569046
[No Abstract] [Full Text] [Related]
3. Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III gene.
Bock SC; Harris JF; Schwartz CE; Ward JH; Hershgold EJ; Skolnick MH
Am J Hum Genet; 1985 Jan; 37(1):32-41. PubMed ID: 2983542
[TBL] [Abstract][Full Text] [Related]
4. The confirmation of preclinical familial antithrombin deficiency using polymorphism and specific oligonucleotide probes .
Beresford CH; Hughes PM; Olds R
N Z Med J; 1990 Jun; 103(892):296-8. PubMed ID: 1973278
[TBL] [Abstract][Full Text] [Related]
5. Analysis for antithrombin gene polymorphisms in Japanese subjects and cosegregation studies in families with hereditary antithrombin deficiency.
Yamazaki T; Katsumi A; Tsuzuki S; Sugiura I; Kojima T; Takamatsu J; Saito H
Thromb Res; 1996 May; 82(3):275-80. PubMed ID: 8732631
[No Abstract] [Full Text] [Related]
6. Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.
Sacks SH; Old JM; Reeders ST; Weatherall DJ; Douglas AS; Winter JH; Rizza CR
J Med Genet; 1988 Jan; 25(1):20-4. PubMed ID: 3162535
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of inherited antithrombin III deficiency.
Prochownik EV; Antonarakis S; Bauer KA; Rosenberg RD; Fearon ER; Orkin SH
N Engl J Med; 1983 Jun; 308(26):1549-52. PubMed ID: 6304514
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of inherited antithrombin III deficiencies.
Prochownik EV
Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168
[TBL] [Abstract][Full Text] [Related]
9. Identification of the antithrombin III Kyoto mutation by restriction fragment length polymorphism analysis.
Masuda H; Tsuji H; Nakagawa K; Nakahara Y; Kitamura H; Ogasahara Y; Nakagawa M
Int J Hematol; 1995 Jun; 61(4):197-204. PubMed ID: 8547608
[TBL] [Abstract][Full Text] [Related]
10. Two new nonsense mutations in type Ia antithrombin III deficiency at Leu 140 and Arg 197.
Tomonari A; Iwahana H; Yoshimoto K; Shigekiyo T; Saito S; Itakura M
Thromb Haemost; 1992 Oct; 68(4):455-9. PubMed ID: 1360174
[TBL] [Abstract][Full Text] [Related]
11. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension.
Zee RY; Ying LH; Morris BJ; Griffiths LR
J Hypertens; 1991 Sep; 9(9):825-30. PubMed ID: 1685742
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidosis IVA: polymorphic haplotypes and informative RFLPs in the Japanese population.
Iwata H; Tomatsu S; Fukuda S; Uchiyama A; Rezvi GM; Ogawa T; Hori T; Nakashima Y; Yamagishi A; Sukegawa K
Hum Genet; 1995 Mar; 95(3):257-64. PubMed ID: 7532616
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
14. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT).
Thein SL; Lane DA
Blood; 1988 Nov; 72(5):1817-21. PubMed ID: 3179448
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic survey of 16 kindreds with hereditary antithrombin III deficiency.
Bock SC; Prochownik EV
Blood; 1987 Nov; 70(5):1273-8. PubMed ID: 3663935
[TBL] [Abstract][Full Text] [Related]
16. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.
Bahnak BR; Lavergne JM; Verweij CL; Rothschild C; Pannekoek H; Larrieu MJ; Meyer D
Thromb Haemost; 1988 Oct; 60(2):178-81. PubMed ID: 2905841
[TBL] [Abstract][Full Text] [Related]
17. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
[TBL] [Abstract][Full Text] [Related]
18. Type I antithrombin deficiency: five novel mutations associated with thrombosis.
Daly M; Perry DJ; Bruce DB; Harper PL; Tait RC; Walker ID; Mayne EE; Daly HM; Brown K; Carrell RW
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):139-43. PubMed ID: 8735803
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
Sakuragawa N; Kondo S; Katoh M; Takahashi K; Koide T
Thromb Res; 1987 Jul; 47(2):147-53. PubMed ID: 3116713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
